EN HU

Dapagliflozin in Patients with Chronic Kidney Disease

Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F. F., Mann, J. F., McMurray, J. J., Lindberg, M., Rossing, P., Sjöström, C. D., Toto, R. D., Langkilde, A. M., Wheeler, D. C., DAPA-CKD Trial Committees and Investigators: Dapagliflozin in Patients with Chronic Kidney Disease.
N. Engl. J. Med. 383 (15), 1436-1446, 2020.
title:
Dapagliflozin in Patients with Chronic Kidney Disease
authors:
  • Heerspink, Hiddo J. L.
  • Stefánsson, Bergur V.
  • Correa-Rotter, Ricardo
  • Chertow, Glenn M.
  • Greene, Tom
  • Hou, Fan-Fan
  • Mann, Johannes F.
  • McMurray, John J.
  • Lindberg, Magnus
  • Rossing, Peter
  • Sjöström, C. David
  • Toto, Roberto D.
  • Langkilde, Anna-Maria
  • Wheeler, David C.
  • DAPA-CKD Trial Committees and Investigators
published:
2020
type:
article
genre:
research article/review article
journal:
New England Journal Of Medicine (ISSN: 0028-4793)
language:
English
HAC:
Health Sciences, Clinical Medicine
DEENK University of Debrecen
© 2012 University of Debrecen